Photo credit: www.sciencedaily.com
Recent research conducted by bioengineers at the University of California San Diego provides new insights into the progression of aortic valve stenosis, a severe heart valve disease, and highlights significant differences between male and female patients. This study reveals that these sex-specific differences are largely influenced by a gene located on the Y chromosome.
Published on March 12 in Science Advances, this groundbreaking discovery emphasizes the importance of understanding how sex chromosomes can affect the way diseases develop and progress, potentially leading to more personalized treatment strategies based on an individual’s biological sex.
“Examining sex differences in medical conditions ultimately benefits all patients,” stated Brian Aguado, the senior author of the study and a professor in the Bioengineering Department at UC San Diego Jacobs School of Engineering. “To truly enhance health outcomes, we have to comprehend how various diseases manifest differently in males and females.”
This study is part of a wider movement toward recognizing the role of sex as a biological variable in medical research. Historically, many investigations have primarily focused on male subjects or male-derived cells, often assuming that sex differences were negligible. However, recent years have seen a growing awareness among researchers and funding bodies about the necessity to incorporate sex-related factors into medical studies.
The implications of this shift are significant for the diagnosis and management of conditions such as aortic valve stenosis. “Our findings indicate that understanding an individual’s chromosome composition is essential for determining effective treatment options,” Aguado emphasized. “A blanket approach to medicine seldom proves effective; focusing on sex differences could enhance outcomes for a broader patient base.”
Aortic valve stenosis (AVS) is a life-threatening condition characterized by the stiffening of the heart’s aortic valve, which obstructs blood flow and elevates the risk of heart failure. The disease manifests differently in males and females: males often develop calcium buildup on the heart valve relatively early, while females tend to experience a stiffening of the valve due to fibrotic tissue formation.
“Though both scenarios result in valve stiffening, the underlying causes differ significantly,” explained Rayyan Gorashi, the study’s first author and a Ph.D. candidate in Aguado’s lab.
Researchers have pinpointed a Y chromosome-linked gene named UTY (ubiquitously transcribed tetratricopeptide repeat containing Y-linked) as a principal catalyst for valve calcification in males.
Investigating Early-Stage Valve Disease
During the onset of AVS, valvular interstitial cells, which are specialized cells of the heart valve, become overly activated. In females, these cells usually transition into myofibroblasts—smooth muscle-like cells that contribute to valve stiffening through fibrosis. Conversely, in males, these myofibroblasts further differentiate into bone-like cells that produce calcium nanoparticles, resulting in valve calcification.
“This research underscores the necessity of exploring the sexual dimorphism observed in aortic valve stenosis,” noted Gorashi. “Understanding the distinct molecular mechanisms at work in males and females could enable the development of sex-specific treatments in the future.”
To investigate these mechanisms, the research team utilized biomaterials to create a hydrogel that simulates the physical properties of aortic valve tissue. They cultured heart valve cells from both sexes on this engineered surface and observed the same sex-based disparities found in actual valve tissues: female cells evolved into myofibroblasts, while male cells proceeded toward becoming bone-like cells. However, these differences disappeared when cells were grown on conventional laboratory Petri dishes.
“In a standard Petri dish, there was no noticeable distinction between male and female cells,” Aguado revealed. “But when we cultured them in an engineered environment that accurately mimicked actual valve tissue, the sex-specific behaviors became apparent. This highlights the necessity of utilizing bioinspired tools to capture physiological variations often overlooked by traditional methods.”
To delve deeper into the mechanisms behind these differences, the researchers incorporated nanoparticles into the hydrogel to emulate calcification sites found in diseased tissue. This addition intensified the observable sex-based differences, supporting the notion that the microenvironment is pivotal in the progression of AVS.
Understanding Chromosomal Roles
The team subsequently directed their focus toward the genetic regulators involved in this process, with an emphasis on the Y chromosome. By implementing gene knockdowns, they identified UTY as a critical gene that influences how male heart valve cells react to their surroundings, steering them toward a calcified state.
“Leveraging engineered tools to uncover previously neglected biological mechanisms is thrilling,” Aguado remarked. “Sex chromosomes have often been regarded simply as indicators of biological sex, but they hold genes that significantly influence cellular function in ways we are just beginning to understand.”
“There is also a significant amount of research still to be conducted concerning the X chromosome’s role,” Gorashi added. “Exploring its mechanisms using specialized biomaterials and examining nanoscale cues in valve tissue could further enrich our understanding of this complex narrative.”
The researchers are gearing up to investigate potential drug targets involving the UTY gene, aiming to find treatments specifically aimed at the early stages of AVS in both males and females.
“We are delving into the foundational science behind how sex chromosomes influence not only disease development but also how cells respond to therapies,” stated Aguado. “Understanding these sex-dependent mechanisms will allow us to devise more effective treatment strategies for a diverse range of patients.”
Source
www.sciencedaily.com